Call it selective reading....but this all has a positive tone to it.
-"During the quarter our established HER-Vaxx Phase 1b gastric cancer study completed and met all study endpoints
with positive top-line results in patients expressing the HER2 target protein were reported"
-"We continue to keep a close eye on costs and manage our resources prudently. Imugene had $24.05 million in the bank as at 31 December 2018."
-"We look forward to providing further updates as we navigate several promising new therapies for multiple cancers
through the clinic and into the hands of the many medical professionals and patients around the world who need
them."
Call it selective reading....but this all has a positive tone to...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |